Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors is a research paper published in New England Journal of Medicine (2020). On theSindex it has a DataRank of 5.4. It has been cited 2,164 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.2
From this paper's citation signal
Citation Network Contribution
4.2
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
National Institutes of Health
Grant: 1 R01 CA211044-01
National Institutes of Health
Grant: 5P01CA148600-03
National Institutes of Health
Grant: CA016672
National Institutes of Health
Grant: P50CA100632-16
NCI NIH HHS
Grant: P01 CA148600
NCATS NIH HHS
Grant: UL1 TR003167
NCI NIH HHS
Grant: P30 CA016672
NCI NIH HHS
Grant: R01 CA211044
NCI NIH HHS
Grant: P50 CA100632
M.D. Anderson Cancer Center CLL and lymphoma Moonshot Grants
MeSH Terms